-
Researchers have developed a genetically engineered probiotic that targets autoimmunity in the brain, a key contributor to diseases such as multiple sclerosis. The probiotic bacteria utilize lactate to regulate immune responses, thus reducing brain inflammation in mouse models with less side effects.
Researchers at Brigham University are working on a novel technique to treat brain autoimmunity by utilizing engineered bacteria to increase both the safety and effectiveness of the [...]
-
Researchers at Brigham are developing a new approach that uses engineered bacteria to more safely and effectively treat autoimmune conditions in the brain.
Brigham researchers are developing a novel method to address autoimmunity in the brain by utilizing engineered bacteria to enhance both the safety and effectiveness of the treatment.
Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have developed a probiotic [...]
-
Les chercheurs ont développé un probiotique génétiquement modifié qui cible l’auto-immunité cérébrale, un facteur clé dans des maladies comme la sclérose en plaques. Les bactéries probiotiques produisent du lactate pour réguler les réponses immunitaires, réduisant ainsi l’inflammation cérébrale chez les modèles murins avec moins d’effets secondaires que les [...]
-
Researchers at Brigham are developing a new approach that uses engineered bacteria to more safely and effectively treat autoimmune conditions in the brain.
Brigham researchers are developing a novel method to address autoimmunity in the brain by utilizing engineered bacteria to enhance both the safety and effectiveness of the treatment.
Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have developed a probiotic [...]
-
Researchers at Brigham are developing a new approach that uses engineered bacteria to more safely and effectively treat autoimmune conditions in the brain.
Brigham researchers are developing a novel method to address autoimmunity in the brain by utilizing engineered bacteria to enhance both the safety and effectiveness of the treatment.
Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have developed a probiotic aimed at [...]
-
Researchers have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks the cells of the central nervous system and is at the core of several diseases, including multiple sclerosis.
In a new study, researchers at Brigham and Women’s Hospital demonstrated the treatment’s potential using preclinical models of these diseases, finding that the technique offered a more precise way to target brain inflammation with reduced [...]
-
Umva Mag
- Publicado em 28 de agosto de 2023
Researchers have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks the cells of the central nervous system and is at the core of several diseases, including multiple sclerosis.
In a new study, researchers at Brigham and Women’s Hospital demonstrated the treatment’s potential using preclinical models of these diseases, finding that the technique offered a more precise way to target brain inflammation with reduced [...]
-
Scientists have demonstrated in mouse studies that specially designed probiotics can reduce brain inflammation associated with diseases like multiple sclerosis. The study points to new potential therapies for hard-to-treat chronic conditions that may be as simple as popping a pill.
They might seem pretty separate, but a growing body of research is showing that the gut and the brain are more deeply intertwined than we thought. Neurological diseases [...]
-
Researchers have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks the cells of the central nervous system.
Autoimmunity in the brain is at the core of several diseases, including multiple sclerosis.
In a new study , researchers at Brigham and Women's Hospital demonstrated the treatment's potential using preclinical models of these diseases, finding that the technique offered a more precise way to target brain inflammation with [...]
-
Researchers have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks the cells of the central nervous system and is at the core of several diseases, including multiple sclerosis.
In a new study, researchers at Brigham and Women’s Hospital demonstrated the treatment’s potential using preclinical models of these diseases, finding that the technique offered a more precise way to target brain inflammation with reduced [...]
